TD Asset Management Inc decreased its stake in Mettler-Toledo International, Inc. (NYSE:MTD – Free Report) by 8.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 169,293 shares of the medical instruments supplier’s stock after selling 14,894 shares during the quarter. TD Asset Management Inc owned approximately 0.83% of Mettler-Toledo International worth $236,027,000 at the end of the most recent quarter.
Several other institutional investors have also bought and sold shares of the stock. Norges Bank bought a new position in Mettler-Toledo International in the 4th quarter valued at $520,989,000. M&T Bank Corp raised its position in Mettler-Toledo International by 2,813.6% in the 4th quarter. M&T Bank Corp now owns 124,205 shares of the medical instruments supplier’s stock valued at $173,165,000 after purchasing an additional 119,942 shares during the last quarter. Alliancebernstein L.P. raised its position in Mettler-Toledo International by 10.7% in the 3rd quarter. Alliancebernstein L.P. now owns 793,927 shares of the medical instruments supplier’s stock valued at $974,633,000 after purchasing an additional 76,478 shares during the last quarter. Northwestern Mutual Wealth Management Co. raised its position in Mettler-Toledo International by 39,107.6% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 61,556 shares of the medical instruments supplier’s stock valued at $85,821,000 after purchasing an additional 61,399 shares during the last quarter. Finally, Bank of America Corp DE raised its position in Mettler-Toledo International by 56.8% in the 3rd quarter. Bank of America Corp DE now owns 128,116 shares of the medical instruments supplier’s stock valued at $157,276,000 after purchasing an additional 46,402 shares during the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.
Analyst Ratings Changes
Several equities analysts have issued reports on MTD shares. Wolfe Research started coverage on Mettler-Toledo International in a research report on Tuesday. They issued a “peer perform” rating for the company. Citigroup dropped their target price on Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating for the company in a research report on Friday, May 8th. Robert W. Baird dropped their target price on Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating for the company in a research report on Monday, May 11th. Wall Street Zen downgraded Mettler-Toledo International from a “buy” rating to a “hold” rating in a research report on Saturday, May 16th. Finally, Jefferies Financial Group upgraded Mettler-Toledo International from a “hold” rating to a “buy” rating and boosted their target price for the stock from $1,400.00 to $1,450.00 in a research report on Friday, March 20th. Six analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $1,408.55.
Mettler-Toledo International Trading Down 0.0%
NYSE MTD opened at $1,169.52 on Thursday. The stock has a 50-day simple moving average of $1,219.42 and a 200 day simple moving average of $1,325.84. The company has a market capitalization of $23.64 billion, a PE ratio of 27.43, a P/E/G ratio of 2.44 and a beta of 1.27. Mettler-Toledo International, Inc. has a 12 month low of $1,023.05 and a 12 month high of $1,525.17.
Mettler-Toledo International (NYSE:MTD – Get Free Report) last released its quarterly earnings data on Thursday, May 7th. The medical instruments supplier reported $8.91 EPS for the quarter, beating analysts’ consensus estimates of $8.70 by $0.21. The business had revenue of $947.13 million during the quarter, compared to the consensus estimate of $943.14 million. Mettler-Toledo International had a negative return on equity of 622.80% and a net margin of 21.40%.The firm’s revenue was up 7.2% on a year-over-year basis. During the same quarter in the prior year, the company posted $8.19 earnings per share. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. As a group, sell-side analysts predict that Mettler-Toledo International, Inc. will post 46.6 earnings per share for the current fiscal year.
About Mettler-Toledo International
Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.
The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.
See Also
- Five stocks we like better than Mettler-Toledo International
- As AI Data Breaches Become More Common, This Cybersecurity ETF Is SurgingAI
- Coke’s $10B India IPO Plan Pops the Top on Hidden Value
- FedEx Unboxes Billions in Post-Spinoff Value
- Marvell’s AI Moment Raises a Bigger Question for Amazon and ServiceNow
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.
